Long-term toxicity studies in dogs support the safety of the special extract ERr 731 from the roots of Rheum rhaponticum

Food and Chemical Toxicology

Volumn 46, Issue 5, 2008, Pages 1608-1618

  Kaszkin Bettag, M ^a   Richardson, A ^b   Rettenberger, R ^c   Heger, P W ^a  

^a Health Research Services Ltd   (Germany)

^b Health Research Services Ltd   (United Kingdom)

^c Carl Mueller Apotheker GmbH U Co KG   (Germany)

Author keywords

Climacteric; Desoxyrhaponticin; Diethylstilbestrol; Estradiol; Herbal drug; Hydroxystilbenes; Phytotherapy; Resveratrol; Rhapontic rhubarb; Rhaponticin

Indexed keywords

ERR 731; GLUCOSE; RHUBARB EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOG; DRUG INDICATION; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; MALE; MENOPAUSAL SYNDROME; NONHUMAN; PLANT ROOT; RHEUM RHAPONTICUM; RHUBARB; TOXICITY TESTING; TREATMENT DURATION;

ANIMALS; BEHAVIOR, ANIMAL; BLOOD CELL COUNT; BLOOD CHEMICAL ANALYSIS; BLOOD GLUCOSE; BODY WEIGHT; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; ELECTROCARDIOGRAPHY; FEMALE; MALE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; ORGAN SIZE; PLANT EXTRACTS; RHEUM; SEX CHARACTERISTICS;

ANIMALIA; CANIS FAMILIARIS; RHEUM RHAPONTICUM; RHEUM X HYBRIDUM;

EID: 40849120767     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2007.12.026     Document Type: Article

References (23)

1. Choi S.B., Ko B.S., Park S.K., Jang J.S., and Park S. Insulin sensitizing and alpha-glucoamylase inhibitory action of sennosides, rheins and rhaponticin in Rhei Rhizoma. Life Sciences 78 (2006) 934-942
2. Couse J.F., Dixon D., Yates M., Moore A.B., Ma L., Maas R., and Korach K.S. Estrogen receptor-alpha knockout mice exhibit resistance to the developmental effects of neonatal diethylstilbestrol exposure on the female reproductive tract. Developmental Biology 238 (2001) 224-238
3. Couse J.F., and Korach K.S. Estrogen receptor-alpha mediates the detrimental effects of neonatal diethylstilbestrol (DES) exposure in the murine reproductive tract. Toxicology 205 (2004) 55-63
4. CPMP/ICH/384/95. 1994. Toxicokinetics: A Guidance for Assessing Systemic Exposure in Toxicology Studies. .
5. CPMP/SWP/1042/99. 2000. Note for guidance on repeated dose toxicity. .
6. Diel P., Schulz T., Smolnikar K., Strunck E., Vollmer G., and Michna H. Ability of xeno- and phytoestrogens to modulate expression of estrogen-sensitive genes in rat uterus: estrogenicity profiles and uterotropic activity. Journal of Steroid Biochemistry and Molecular Biology 73 (2000) 1-10
7. Diel P., Geis R.B., Caldarelli A., Schmidt S., Leschowsky Laudenbach U., Voss A., and Vollmer G. The differential ability of the phytoestrogen genistein and of estradiol to induce uterine weight and proliferation in the rat is associated with a substance specific modulation of uterine gene expression. Molecular and Cellular Endocrinology 221 (2004) 21-32
8. Fink, D.J., 1978. DES Task Force Summary Report. Washington, D.C. Government Printing Office (DHEW publication No. NIH 79-1688).
9. Heger M., Ventskovskiy B.M., Borzenko I., Kneis K.C., Rettenberger R., Kaszkin-Bettag M., and Heger P.W. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12-week randomized, double-blind, placebo-controlled trial. Menopause 13 (2006) 744-759
10. Herbst A.L., Ulfelder H., Poskanzer D.C., and Longo L.D. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. American Journal of Obstetrics and Gynecology 181 (1999) 1574-1575
11. Holinka C.F., Hata H., Kuramoto H., and Gurpide E. Effects of steroid hormones and antisteroids on alkaline phosphatase activity in human endometrial cancer cells (Ishikawa line). Cancer Research 46 (1986) 2771-2774
12. International Agency for Research on Cancer IARC. 1979. Sex Hormones (II). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 21, pp. 173-231.
13. Kuiper G.G.J.M., Lemmen J.G., Carlson B., Corton J.C., Save S.H., Van der Saag P.T., Van der Burg B., and Gustafsson J.A. Interactions of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 (1998) 4252-4263
14. Marselos M., and Tomatis L. Diethylstilboestrol: I, Pharmacology, Toxicology and carcinogenicity in humans. European Journal of Cancer 28A (1992) 1182-1189
15. Marselos M., and Tomatis L. Diethylstilboestrol: II, pharmacology, toxicology and carcinogenicity in experimental animals. European Journal of Cancer 29A (1993) 149-155
16. McClain R.M., Wolz E., Davidovich A., Pfannkuch F., and Bausch J. Subchronic and chronic safety studies with genistein in dogs. Food and Chemical Toxicology 43 (2005) 1461-1482
17. Moggs J.G., Ashby J., Tinwell H., Lim F.L., Moore D.J., Kimber I., and Orphanides G. The need to decide if all estrogens are intrinsically similar. Environmental Health Perspectives 112 (2004) 1137-1142
18. ®), its aglycones and structurally related compounds in U2OS human osteosarcoma cells. Phytomedicine 14 (2007) 716-726
19. Paech K., Webb P., Kuiper G.G.J.M., Nilsson S., Gustafsson J.A., Kushner P.J., and Scanlan T.S. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277 (1997) 1508-1510
20. Rupprich N., Hildebrand H., and Kindl H. Substrate specificity in vivo and in vitro in the formation of stilbenes. Biosynthesis of rhaponticin. Archives of Biochemistry and Biophysics 200 (1980) 72-78
21. In: Shayne C.Gad. (Ed). Animal Models in Toxicology. second ed. (2007), CRC Press, Taylor and Francis Group, Boca Raton, FL
22. ®), its aglycones and structurally related compounds. Journal of Steroid Biochemistry and Molecular Biology 107 (2007) 191-201
23. Zhu B.T., Han G.Z., Shim J.Y., Wen Y., and Jiang X.R. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor α and β subtypes: insights into the structural determinants favoring a differential subtype binding. Endocrinology 147 (2006) 4132-4150